These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modeling the behavior of uveal melanoma in the liver. Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861 [TBL] [Abstract][Full Text] [Related]
6. Vasculogenic mimicry and tumor angiogenesis. Folberg R; Hendrix MJ; Maniotis AJ Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364 [TBL] [Abstract][Full Text] [Related]
7. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228 [TBL] [Abstract][Full Text] [Related]
8. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832 [TBL] [Abstract][Full Text] [Related]
9. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493 [TBL] [Abstract][Full Text] [Related]
10. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332 [TBL] [Abstract][Full Text] [Related]
11. Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells. Cong R; Sun Q; Yang L; Gu H; Zeng Y; Wang B J Exp Clin Cancer Res; 2009 Sep; 28(1):124. PubMed ID: 19735546 [TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas. Bhat P; Jakobiec FA; Folberg R Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353 [TBL] [Abstract][Full Text] [Related]
13. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306 [TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2). Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732 [TBL] [Abstract][Full Text] [Related]
15. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry. Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698 [TBL] [Abstract][Full Text] [Related]
17. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse. Ozerdem U Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406 [TBL] [Abstract][Full Text] [Related]
18. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372 [TBL] [Abstract][Full Text] [Related]
19. Remodeling of the microenvironment by aggressive melanoma tumor cells. Hendrix MJ; Seftor EA; Kirschmann DA; Quaranta V; Seftor RE Ann N Y Acad Sci; 2003 May; 995():151-61. PubMed ID: 12814947 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry. Zhang R; Chen X; Chen S; Tang J; Chen F; Lin Y; Reinach PS; Yan X; Tu L; Duan H; Qu J; Hou Q Cell Oncol (Dordr); 2022 Aug; 45(4):557-572. PubMed ID: 35716258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]